Abstract
Carbachol (025—1.0 µg), injected into the physostigmine-containing Ringer-Locke-perfused cat superior cervical ganglion, released acetylcholine (ACh; 19.0-29.0 mµg) into the effluent; ACh release was markedly reduced (to 7.0-8.0 mµg) by chronic (12-16 days) preganglionic denervation. N-Methylcarbachol (0.5-7.0 µg) caused the release of a maximum of 10.0 mµg and N,N-dimethylcarbachol produced no detectable release of ACh; the threshold doses of the N-methyl analogs for activation of ganglia with normal circulation were not increased by chronic preganglionic denervation. Continuous infusions of carbachol (10-6 or 10-5 M) in Ringer-Locke solution containing hemicholinium (2 x 10-5 M) for 1 hr produced no reduction in ganglionic ACh stores, whereas repeated injections of carbachol (12 x 1.0 µg) over the same period caused a reduction of approximately 25%. Increasing the Ca++ concentration of the Ringer-Locke solution from 2.17 to 4.34 or 8.68 mM resulted in an increase in ACh release by preganglionic stimulation, but reduced or blocked ACh release by carbachol (1.0 µg); conversely, in the absence of Ca++ from the perfusion solution ACh release by preganglionic stimulation was prevented, but ACh release by carbachol was not, even in the presence of ethylene glycol tetraacetic acid (10-3 M). It is concluded that ACh release by carbachol can result from more than one mechanism or site, depending upon the experimental conditions.
Footnotes
- Received December 19, 1966.
- Accepted March 21, 1967.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|